Diagnosis Code J84.02
Information for Medical Professionals
The diagnosis code J84.02 is grouped in the following Diagnostic Related Group(s) (MS-DRG V34.0)
- 196 - INTERSTITIAL LUNG DISEASE WITH MCC
- 197 - INTERSTITIAL LUNG DISEASE WITH CC
- 198 - INTERSTITIAL LUNG DISEASE WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 516.2 - Pulm alveolar microlith
- Calcification of lung
- Diffuse pulmonary calcinosis
- Pulmonary alveolar microlithiasis
- Pulmonary ossification
Information for Patients
Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.
Breathing in dust or other particles in the air is responsible for some types of interstitial lung diseases. Specific types include
- Black lung disease among coal miners, from inhaling coal dust
- Farmer's lung, from inhaling farm dust
- Asbestosis, from inhaling asbestos fibers
- Siderosis, from inhaling iron from mines or welding fumes
- Silicosis, from inhaling silica dust
Other causes include autoimmune diseases or occupational exposures to molds, gases, or fumes. Some types of interstitial lung disease have no known cause.
Treatment depends on the type of exposure and the stage of the disease. It may involve medicines, oxygen therapy, or a lung transplant in severe cases.
- Hypersensitivity pneumonitis
- Interstitial lung disease
- Interstitial lung disease - adults - discharge
- Pulmonary function tests
Pulmonary alveolar microlithiasis Pulmonary alveolar microlithiasis is a disorder in which many tiny fragments (microliths) of a compound called calcium phosphate gradually accumulate in the small air sacs (alveoli) located throughout the lungs. These deposits eventually cause widespread damage to the alveoli and surrounding lung tissue (interstitial lung disease) that leads to breathing problems. People with this disorder can develop a persistent cough and difficulty breathing (dyspnea), especially during physical exertion. Affected individuals may also experience chest pain that worsens when coughing, sneezing, or taking deep breaths.Pulmonary alveolar microlithiasis is usually diagnosed before age 40. Often the disorder is discovered before symptoms develop, when medical imaging is done for other reasons. The condition typically worsens slowly over many years, although some affected individuals have signs and symptoms that remain stable for long periods of time.People with pulmonary alveolar microlithiasis can also develop calcium phosphate deposits in other organs and tissues of the body, including the kidneys, gallbladder, testes, and the valve that connects a large blood vessel called the aorta with the heart (the aortic valve). In rare cases, affected individuals have complications related to accumulation of these deposits, such as a narrowing (stenosis) of the aortic valve that can impede normal blood flow.